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EFFECT OF RPON, RPOS AND LUXS PATHWAYS ON THE BIOFILM
FORMATION AND ANTIBIOTIC SENSITIVITY OF BORRELIA
BURGDORFERI
Eva Sapi*, Priyanka A. S. Theophilus, Truc V. Pham, Divya Burugu, David F. Luecke
Department of Biology and Environmental Science, University of New Haven, West Haven, CT 06516, USA
Received: July 20, 2016; Accepted: August 15, 2016
Borrelia burgdorferi, the causative agent of Lyme disease, is capable of forming biofilm in vivo and in vitro, a structure well known 
for its resistance to antimicrobial agents. For the formation of biofilm, signaling processes are required to communicate with the 
surrounding environment such as it was shown for the RpoN–RpoS alternative sigma factor and for the LuxS quorum-sensing path-
ways. Therefore, in this study, the wild-type B. burgdorferi and different mutant strains lacking RpoN, RpoS, and LuxS genes were 
studied for their growth characteristic and development of biofilm structures and markers as well as for their antibiotic sensitivity. 
Our results showed that all three mutants formed small, loosely formed aggregates, which expressed previously identified Borrelia 
biofilm markers such as alginate, extracellular DNA, and calcium. All three mutants had significantly different sensitivity to doxy-
cyline in the early log phase spirochete cultures; however, in the biofilm rich stationary cultures, only LuxS mutant showed in-
creased sensitivity to doxycyline compared to the wild-type strain. Our findings indicate that all three mutants have some effect on 
Borrelia biofilm, but the most dramatic effect was found with LuxS mutant, suggesting that the quorum-sensing pathway plays an 
important role of Borrelia biofilm formation and antibiotic sensitivity.
Keywords: Lyme disease, biofilm, sigma factor, quorum sensing, mucopolysaccharides, alginate, eDNA
Abbreviations: BSA, bovine serum albumin; BSK-H, Barbour–Stoner–Kelly H; DAPI, 4',6-diamidino-2-phenylindole; DDAO, 
7-hydroxy-9H-(1,3-dichloro-9,9 dimethylacridin-2-one; DIC, differential interference contract microscopy; EDTA, ethylenediami-
netetraacetic acid; EPS, extracellular polymeric substances; FITC, fluorescein isothiocyanate; PBS, phosphate-buffered saline; 
RT, room temperature; TE, Tris–EDTA
Introduction
Lyme disease is the most common tick-borne illness 
caused by the species of bacteria belonging to the genus 
Borrelia [1]. According the Center of Disease Control 
within the United States, there are approximately 300,000 
reported new Lyme disease cases every year while there 
are 65,000 people per year reported in Europe [2]. Patients 
diagnosed with Lyme disease are treated with certain anti-
biotics; however, recent studies demonstrated those antibi-
otics insuffi cient in eliminating certain forms of Borrelia 
in vitro [3–6]. Furthermore, several clinical [7–12] and in 
vivo studies [13–18] suggested that there are a potential 
resistant form which can withhold the antibiotic treatments 
and the attack of the immune system.
Numerous studies demonstrated that Borrelia burgdor-
feri can adopt diverse morphologies such as spirochete, 
round bodies (cysts and granules), and cell defi cient forms 
depending on the condition of the environment they are 
exposed to [19–23]. These forms provide protective envi-
ronment for Borrelia for adverse environmental conditions 
such as exposure to antibiotics, starvation, pH changes, or 
even high temperature [24–31]. In these defensive forms, 
B. burgdorferi becomes dormant and remains in this mor-
phological state until it fi nds a more favorable condition 
when it returns to its spirochete form [27–31].
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Recently, we provided evidences that B. burgdorferi 
sensu stricto and sensu lato stains are capable of form-
ing another defensive form called biofi lm both in vitro and 
in vivo [32, 34]. We also suggested that Borrelia biofi lm 
formation could result in increased resistance to various 
antibiotics [3, 35]. Numerous studies showed that one of 
the most effective hiding places for a bacterial species is 
biofi lm [36, 37]. Bacterial biofi lms are organized commu-
nities of cells enclosed in a self-produced hydrated poly-
meric matrix called extracellular polymeric substances 
(EPS) which are complex mixtures of polysaccaharides, 
lipids proteins, nucleic acids, and other macromolecules 
[36–39]. Elimination of pathogenic bacteria in their bio-
fi lm form is very challenging because these sessile bacte-
rial cells can endure not just the host immune responses 
but they are much less susceptible to antibiotics or any 
other industrial biocides than their individual planktonic 
counterparts [38, 39]. The biofi lm resistance is based upon 
multiple mechanisms, such as incomplete penetration of 
certain antibiotics deep inside the matrix and/or inactiva-
tion of antibiotics by altered microenvironment within the 
biofi lm and a highly protected resistant bacteria population 
called persisters [39].
When we evaluated the possibilities that observed Bor-
relia aggregates are indeed biofi lm structures, its important 
biofi lm traits like structural rearrangements and changes in 
development on different substrate matrices as well as the 
different components of the extracellular protective poly-
meric surface were studied [32, 33]. Our atomic force mi-
croscopic results provided evidence that, at various stages 
of aggregate development, rearrangements take place at 
multiple levels that lead to a continuously complex rear-
ranging structure [32]. When the EPS of the aggregates 
was studied for potential exopolysaccharides, both sulfat-
ed and non-sulfated/carboxylated substrates were found; 
however, the majority was non-sulfated polymucosac-
charide alginate. We provided evidence that the Borrelia 
EPS matrix also contains calcium and extracellular DNA 
[32, 33].
The important molecular pathways of Borrelia biofi lm 
development are not known; therefore, to better under-
stand the key components, the potential role of the several 
important signaling pathways was studied using wild-type 
and mutant B. burgdorferi sensu stricto strain 297.
The fi rst pathway targeted was the RpoN–RpoS al-
ternative sigma factor pathways, which can be found in 
many bacterial species, and they are involved in various 
cellular functions in response to different environmental 
stresses such as adverse temperature, high/low pH, high 
osmolarity, oxidative stress, high cell density, and carbon 
starvation [40]. They also control important virulence 
factors, and they are required for successful infection by 
many pathogenic bacteria [40]. The RpoN–RpoS pathway 
in B. burgdorferi has similar functions and responsible 
for sensing the environmental cues and activating RpoN 
encoded for σN which then regulates another alternative 
sigma factor, σS [41–45]. It was shown that this two-com-
ponent RpoN–RpoS signal-transduction pathway controls 
the successful transmission of B. burgdorferi from the ar-
thropod vector to the vertebrae host by regulating the ex-
pression of several known virulence factors such as outer 
surface proteins (OspA, OspB, OspC), decorin and fi bro-
nectin binding proteins as well as other proteins [44–46]. 
RpoS-mediated adaptive response is directly regulated by 
RpoN in B. burgdorferi, and together, they regulate over 
100 different genes important in survival and stress re-
sponses as well as genes involved in the infectious cycles 
of B. burgdorferi [44–46].
Another important global regulatory pathway in bac-
teria is the quorum sensing bacterial intercommunication 
system that controls the expression of multiple genes in 
response to population density [47–50]. The system uti-
lizing small signal molecules is called autoinducers. As 
the cell population density increases, autoinducers accu-
mulate and cause a population-wide change in the ex-
pression of different genes involved in biofi lm formation 
[49, 50]. It was previously demonstrated that B. burg-
dorferi utilizes the autoinducer-2 as one of its many 
ways of communication [51, 52]; however, one study 
challenged this observation [53]. The importance of this 
quorum-sensing pathway in biofi lm development was 
shown for several pathogenic bacteria [54, 55]. For ex-
ample, a luxS mutant of Streptococcus gordonii, a major 
component of dental plaque biofi lm, was unable to form 
a mixed-species biofi lm with another pathogen Porphy-
romonas gingivalis [54]. Furthermore, the luxS mutant of 
Streptococcus spp. shows altered biofi lm structure [55]. 
All these data suggest that LuxS quorum sensing system 
might play an important role in B. burgdorferi biofi lm 
formation.
In this study, different B. burgdorferi strains includ-
ing the wild-type 297 and several mutant strains such as 
RpoN, RpoS, and LuxS mutants were studied to evaluate 
the effect of the deletion of these genes on biofi lm for-
mations and biofi lm specifi c markers as well as antibiotic 
sensitivity of B. burgdorferi in order to better understand 
the molecular pathways involved in biofi lm formation and 
its antibiotic resistance. Several previously described Bor-
relia biofi lm markers such as sulfated/non-sulfated poly-
saccharides, alginate, extracellular DNA, and calcium 
were analyzed using immunohistochemistry and different 
staining techniques such as Spicer–Meyer, Alizarin, and 
extracellular DNA staining methods [32, 33]. The ob-
tained results were visualized using various microscopic 
techniques such as dark and bright fi eld, fl uorescent, and 
differential interference contrast microscopy. In addition, 
the antibiotic sensitivity of the different forms (spirochete 
and biofi lm) of the wild-type and mutant Borrelia strains 
was also evaluated.
In summary, the aim of this study to provide insight of 
the potential molecular pathways regulating biofi lm for-
mation in B. burgdorferi using different mutant cell lines 
with the fi nal goal to better understand how B. burgdorferi 
forms biofi lms. Data from this study might provide mo-
lecular targets in the future to the elimination of Borrelia 
biofi lms for therapeutic use.
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Materials and methods
Borrelia strains and culture conditions
Low passages (not more than three passages) of the wild-
type 297 and mutant strains (RpoN, RpoS, and LuxS) 
of B. burgdorferi were generously provided by Michael 
V. Norgard’s research group (Department of Microbiol-
ogy, University of Texas South-western Medical Center, 
Dallas, Texas). All strains were cultured in BSK-H (Bar-
bour–Stoner–Kelly H) media with 6% rabbit serum (Peel-
Freeze) by incubating at 33 °C and 5% CO2. For all the 
stock mutant strains, appropriate amounts of antibiotics 
were added to culture media, maintaining the mutation as 
described previously [41, 53]. To visualize biofi lm forma-
tion, 1 × 106 cells/ml of wild-type and mutant strains of 
B. burgdorferi were inoculated in four-well chamber glass 
slides (Thermo Fisher Scientifi c, Lab-Tek II chamber glass 
slides) and were incubated for 7 days at 33 °C and 5% 
CO2. For biofi lm quantitative assays, 1 × 10
6 cells/ml of 
wild-type and mutant strains of B. burgdorferi were inocu-
lated in a 48-well tissue culture plates without any antibi-
otics and incubated for different times as described below.
Spicer & Meyer mucopolysaccharide staining
The wild-type 297, RpoN, RpoS, and LuxS mutant strains 
of B. burgdorferi were incubated as described above for 
7 days. These aggregates were fi xed on the slides with 
chilled (−20 °C) 1:1 mixture of acetone–methanol for 
5 min. Aldehyde fuchsine solution (Sigma-Aldrich, 0.5% 
fuchsine dye, 6% acetaldehyde in 70% ethanol with 1% 
concentrated hydrochloric acid) was used to stain the 
biofi lm for 20 min at room temperature (RT). The slides 
were dipped in 70% ethanol for 1 min and then rinsed with 
 double distilled water for 1 min followed by staining with 
1% Alcian blue 8GX (Sigma-Aldrich, dissolved in 3% 
acetic acid, pH 2.5) for 30 min at RT. Then, after rinsing 
the slides with double distilled water for 3 min, they were 
dehydrated with graded ethanol (50%, 70%, and 95%, 
3 min each), then dipped in chilled xylene for 2 min, and 
were mounted with Permount media (Fisher Scientifi c).
Immunohistochemistry
Anti-alginate rabbit polyclonal IgG antibody (generous 
gift from G. Pier, Harvard University) was used to detect 
alginate expression by the aggregates of the wild-type 297, 
RpoN, RpoS, and LuxS mutant strains of B. burgdorferi. 
Biofi lms were established and cultured as described above 
on four-well chamber slides for 7 days. The resulting 
structures were washed twice with PBS pH 7.4 and fi xed 
in −20 °C using 100% methanol for 10 min and washed 
then twice with PBS pH 7.4 at RT. The specimens were 
then pre-incubated with 10% normal goat serum (Thermo 
Scientifi c) in PBS/0.5% bovine serum albumin (BSA, Sig-
ma) for 30 min at RT to block nonspecifi c binding of the 
secondary antibody. Then, the primary alginate antibody 
(1:100 dilution in dilution buffer: PBS pH 7.40 + 0.5% 
BSA) was applied and the slides were incubated over-
night at 4 °C in a humidifi ed chamber. After washing, 
specimens were incubated for ½ h with a 1:200 dilution 
of DyLight 594 conjugated goat anti-rabbit IgG (Thermo 
Scientifi c) at RT. The slides were then washed thrice with 
PBS/0.5% BSA for 10 min, then incubated at 37 °C for 1 h 
with FITC-labeled Borrelia-specifi c polyclonal antibody 
(#73005 Thermo Scientifi c, diluted 1:50 in 1% BSA/1× 
PBS, pH 7.4). It was followed by further washing of slides 
thrice with PBS/0.5% BSA for 10 min at RT and counter-
staining with 4',6-diamidino-2-phenylindole (DAPI) for 
10 min. Then, after washing it again with PBS pH 7.4 for 
5 min at RT, the specimens were mounted using Perma-
Fluor aqueous mounting medium and the obtained images 
were analyzed by fl uorescent microscopy.
Alizarin calcium staining
In order to evaluate the presence of calcium on the surface 
of B. burgdorferi biofi lms, 1 × 106 cells/ml of wild-type 
and mutant strains of Borrelia were grown in four-well 
chamber slides for 7 days, washed twice with PBS pH 7.4, 
fi xed with ice-cold acetone for 5 min, and hydrated with 
graded alcohol and then stained with 2% Alizarin Red-S 
pH 4.2 (Sigma-Aldrich #A5533) (calcium-specifi c stain) 
for 4 min at RT and then were washed twice with double 
distilled water, dehydrated, and mounted with Permount 
media.
Extracellular DNA staining
To evaluate the extracellular DNA on the aggregates and 
individual spirochetes, 1 × 106 cells/ml of the wild-type 
297 and RpoN, RpoS, and LuxS mutant strains of B. burg-
dorferi were grown on four-well chamber slides for 7 days. 
The resulting aggregates washed twice with 1× TE buffer 
pH 8.0. The extracellular DNA was visualized by stain-
ing the biofi lms with 1 μM DDAO [7-hydroxy-9H-(1,3-
dichloro-9,9 dimethylacridin-2-one)] for 30 min at 37 °C 
in dark. The slides were then washed twice in 1× TE buffer 
pH 8.0 and mounted with PermaFluor aqueous mounting 
medium (Thermo Scientifi c).
Quantification of  B. burgdorferi biofilms by crystal
violet and total carbohydrate methods
The overall mass of the wild-type and mutant Borrelia bio-
fi lms was quantifi ed by crystal violet methods described 
earlier [3, 34]. Briefl y, seven-day-old aggregates (starting 
culture of 5 × 106 spirochetal cells) were scraped from the 
slides and collected by centrifugation method (5000g for 
10 min at RT) and were stained with 0.01% (w/v) crys-
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tal violet 10 min at room temperature. The crystal violet 
stain was discarded by centrifugation method (5000g for 
10 min at room temperature) and washed twice with sterile 
double-distilled water to remove all traces of crystal violet 
dye; then, 100 microliter 95% ethanol was added and in-
cubated for 15 min at RT, and absorbance was measured at 
595 nm using a BioTek spectrophotometer.
Total carbohydrate assay was also used to detect all 
forms of carbohydrates, including simple and complex sac-
charides, glycans, glycoproteins, and glycolipids as recent 
studies utilized successfully this method to measure and 
quantify the formation of extrapolysaccaharide layer of the 
biofi lms as described earlier [32]. Briefl y, seven-day-old 
aggregates (starting culture of 5 × 106 spirochetal cells) 
were scraped from the slides and collected by centrifuga-
tion method (5000g for 10 min at RT). After removing the 
supernatant, pellets were resuspended in double-distilled 
H20 (0.2 mL) followed by 5% aqueous phenol (wt/vol, 
Sigma) and 0.5 ml of concentrated sulfuric acid (H2SO4) 
and incubated for 30 min at RT. The developed yellow/or-
ange color was measured at 485 nm using a BioTek spec-
trophotometer.
Baclight (Live/Dead) staining of  Borrelia aggregates
To visualize live and dead cells for Borrelia aggregates, 
Baclight Live/Dead viability staining kit (Invitrogen) was 
used following manufacturer instructions. Briefl y, a 1:1 
mixture of SYTO9 and propidium iodide stain prepared 
above was added directly to the cultures in the four-cham-
ber glass slides. The plate was then covered with alumi-
num foil and incubated for 15 min at RT. The four cham-
bers were separated from the slide, washed, and mounted, 
and pictures were taken under the Leica microscope using 
fl uorescent microscopy.
Spirochete growth inhibition assay
For all antimicrobial sensitivity assays, early log-phase 
spirochete cultures (5 × 105 cells/ml) from the wild-type 
and mutant strains were prepared in fresh medium with-
out antibiotics and treated with different concentration of 
doxycyline for 48 h of treatment. Spirochete count was es-
timated by direct counting of live/motile spirochetes dark 
fi eld microscopy. Six replicates were prepared for each 
treatment condition and three independent experiments 
were performed. Percentage of control was calculated by 
normalization of spirochete counts to the control treatment 
(no doxycycline) of the same strain.
Biofilm microbial sensitivity assay
Seven-day-old aggregates (starting culture of 5 × 106 spi-
rochetal cells) in 1 mL suspension were treated with dif-
ferent concentration of doxycycline for 48 h days. Six 
replicates were prepared for each treatment condition, and 
three independent experiments were performed. After the 
treatment period, aggregates are quantifi ed by crystal vio-
let and sulfuric acid-phenol digestion total carbohydrate 
assay.
Statistical analysis
Each assay was carried out in three independent experi-
ments with six replicates/condition, and numerical average 
was obtained for data presentation. Unpaired, two-tailed 
TTEST of unequal variance sample was performed to de-
termine p values and statistical difference of two distinct 
sample sets. Differences were considered statistically sig-
nifi cant when p values are <0.05.
Results
The growth pattern of  B. burgdorferi wild-type
and mutant strains
Evaluation of spirochete growth pattern in the wild-type 
and mutant B. burgdorferi 297 strains from day 0 to day 8 
were performed by using 8 × 105/ml spirochetes and cul-
tured as described in Materials and methods. The results 
of the obtained growth curves showed the standard three-
phase growth: lag, exponential/log, and stationary growth 
(Fig. 1). Doubling time of all mutants (RpoNΔ, RpoSΔ, 
and LuxS∆) was similar to that of the 297 wild-type strain. 
Fig. 1. The dynamic of the spirochetal growth of the wild-type 
and mutant B. burgdorferi 297 strains. Spirochetes at starting 
concentration at 8 × 105 cells/ml were cultured for 8 days as 
described in Materials and methods, and their cellular growth 
was evaluated by direct counting method of motile spirochetes 
using dark field microscopy. Each time point was carried out in 
three independent experiments with six replicates/condition
Effect of different pathways on Borrelia biofilm
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However, RpoN and RpoS mutants exhibited a delay in 
the transition from exponential/log phase to stationary 
growth, resulting in a higher maximum spirochete den-
sity: 1 × 108 compared to 5 × 107 in wild type. Figure 1 
demonstrates that the RpoN mutant entered the stationary 
growth only on day 6, followed by RpoS mutant and wild-
type 297 strains on day 4. On the other hand, LuxS mutant 
displayed a longer log phase compared to other strains but 
still had maximal spirochete density that was similar to 
wild-type strain on day 8.
Analysis of aggregates formed by different mutant 
strains and wild type of  B. burgdorferi strains
In the next experiments, the aggregates produced by the 
wild-type and mutant strains of B. burgdorferi were ana-
lyzed by dark fi eld microscopy. Microscopic pictures of 
Borrelia strains on glass slides of the four-well chambers 
after 7 days of incubation of 5 × 106 cells/ml seeding con-
centration were compared for the presence of potential ag-
gregate presence. The result showed that aggregates were 
formed in the 297 wild type as well as all three mutant cul-
tures (Fig. 2). Morphologically, mutants seemed to exhibit 
a higher tendency to form loose, dispersed, and smaller 
aggregates than wild-type strain, especially LuxS∆ mutant 
strains, which showed a reticular mesh structure (Fig 2).
The quantifi cation of aggregates formed by different 
mutant and wild-type strains was performed using crystal 
violet and total carbohydrate methods (Fig. 3A and B, re-
spectively). When crystal violet method used to measure 
the total mass of the different aggregates, there was a sig-
nifi cant reduction in the aggregate formation by RpoNΔ 
strain when compared to the wild-type 297 strain (22% 
reduction, p < 0.05). Comparing RpoSΔ and LuxS∆ ag-
gregates to the wild-type strain, there was a 16% reduc-
tion and 39% in the total aggregate masses, respectively 
(p < 0.05). Interestingly, when total carbohydrate method 
was used to quantify the total carbohydrate component of 
the different aggregates, no signifi cant difference could be 
found between the different mutant and wild-type strains 
(Fig. 3B).
Presence of specific biofilm markers on the surface of 
the aggregates of different B. burgdorferi strains
Wild-type 297 and various mutant strains of B. burgdorferi 
were tested for the presence of the previously described 
Borrelia biofi lm specifi c markers such as sulfated/non-
sulfated polysaccharides, alginate, calcium, and extracel-
lular DNA.
1. Sulfated/non-sulfated mucins
Spicer & Meyer staining method was used to examine the 
presence of sulfated and non-sulfated/carboxylated mu-
cins. Fuchsine stains the weakly acidic sulfomucins; pur-
ple coloration signifi es strongly acidic sulfomucins, and 
alcian blue stain is specifi c for non-sulfated/carboxylated 
mucins. The aggregates formed by the wild-type and the 
Fig. 2. Representative images of aggregates formed by 297-WT (A), RpoN∆ (B), RpoS∆ (C), and LuxS∆ 
(D) strains of B. burgdorferi as depicted by dark field microscopy. 400× magnification, bar: 200 μm
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different mutant strains (RpoN∆, RpoS∆, and LuxS∆) of 
B. burgdorferi were stained as described in Materials and 
methods and imaged with dark fi eld microscopy (Fig. 4). 
The colors developed in the center of the all three mutant 
Fig. 3. Quantitative analysis of the total mass content of the aggregates formed by 297-WT, RpoNΔ, RpoSΔ, and LuxSΔ using crys-
tal violet method (panel A) or total carbohydrate methods (panel B). Each assay was carried out in three independent experiments 
with six replicates/condition. *p values < 0.05 indicates statistical significance as related to the 297-WT control strain
Fig. 4. Spicer & Meyer mucopolysaccharide staining by dark field microscopy of the wild-type 297 (A) and the mutant RpoN (B), 
RpoS (C), and LuxS (D) B. burgdorferi strains. Fuchsia color indicates weakly acidic sulfomucins; purple color indicates strongly 
acidic sulfomucins/sulfated proteoglycans; blue color indicates non-sulfated/carboxylated mucins. 400× magnification, bar: 200 μm
Effect of different pathways on Borrelia biofilm
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strains showed some blue staining pattern (non-sulfated 
mucin), but contrary to wild-type 297, it was very dis-
persed. The periphery of the biofi lms of all mutant strains 
studied stained mainly fuchsia purple color indicating sul-
fated mucins similar to the mucins found in the 297 wild-
type strain.
2. Alginate
Spicer & Meyer mucopolysaccharide staining results 
showed the presence of some non-sulfated mucins on all of 
the mutant strain biofi lms. The non-sulfated mucins could 
indicate the presence of alginate as described previously 
for both B. burgdorferi B31 and 297 strains [32, 33]. The 
presence of alginate on the surface of the wild-type and 
the mutant strains of Borrelia species was confi rmed by 
performing a previously published and validated method 
of double immunohistochemical staining with anti-algi-
nate and anti-Borrelia antibodies (Fig. 5A–K). All mutant 
strains, RpoN, RpoS, and LuxS, were strongly stained 
with anti-Borrelia (Fig. 5D, G, and J) and anti-alginate an-
tibodies (Fig. 5E, H, and K) similar to the wild-type 297 
strains (Borrelia – green staining, Fig. 5A; alginate – red 
staining, Fig. 5B, respectively). Similarly to the wild-type 
strain, only the center of the aggregates stained with al-
Fig. 5. Immunohistochemical staining of wild-type 297, RpoN, RpoS, and LuxS mutant strains of B. burgdorferi with Borrelia-
specific (green staining, panels A, D, G, and J) and alginate antibodies (red staining, panels B, E, H, and K) as described in Materi-
als and methods. DAPI counterstain (blue staining, panels C, F, I, and L) indicates nuclear staining. Yellow arrowheads indicate 
spirochetes not stained with alginate. 400× magnification, bar: 200 μm
E. Sapi et al.
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ginate antibody but not the surrounding spirochetes, indi-
cating the specifi city of the alginate staining technique as 
well as that fact that individual spirochetes do not express 
alginate (yellow arrow) as described in our previous re-
ports [32, 34].
3. Presence of calcium
It was previously reported that alginate is associated with 
calcium to form insoluble calcium alginate and calcium 
was found on the surface of both B. burgdorferi B31 and 
297 strains. The potential presence of calcium on the sur-
face of different aggregates formed by the wild-type and 
the different mutant strains was tested by using Alizarin 
calcium staining method. The aggregates of all mutant 
strains RpoN, RpoS, and LuxS were stained red color with 
Alizarin Red-S stain similar to the wild-type 297 strain, 
indicating the presence of calcium in all strains studied 
(Fig. 6, panels A, B, C, and D). As previously reported for 
the wild-type 297 strain [32], the individual spirochetes 
were not stained with the calcium stain (indicated in Fig. 6 
with black arrowheads), suggesting that calcium is specifi c 
to the surface of the aggregates formed by the wild-type 
and all mutants strains studied.
4. Extracellular DNA
Finally, the aggregates formed by the wild-type and mu-
tant strains were examined for the presence of extracel-
lular DNA (eDNA) as it was described for B. burgdorferi 
biofi lm before [32]. For the detection of eDNA, a red fl uo-
rescent dye (7-hydroxy-9H-(1,3-dichloro-9,9-dimethyl-
acridin-2-one (DDAO)) was used as reported previously 
[32]. The aggregate surfaces of the wild-type 297 and the 
RpoN, RpoS, and LuxS mutant strains were found to have 
signifi cant amount of eDNA (Fig. 7, panels B, D, F, and 
H, respectively) whereas the surrounding individual spiro-
chetes did not show staining for eDNA (indicated by yel-
low arrowheads). The DAPI nuclear counter stain images 
(Fig. 7, panels A, C, E, and G) depicted the size and mor-
phology of the wild-type and mutant aggregates.
Effect of doxycyline on the wild-type and different
mutant strains of  B. burgdorferi
The goal of the next experiments is to compare the response 
of the early log phase spirochetal rich and stationary phase 
aggregate rich cultures of the wild-type and mutant strains 
to antibiotic stress. The effects of doxycycline on the spi-
rochetal form of B. burgdorferi in the wild-type 297 and 
mutant strains (RpoN∆, RpoS∆, and Lux∆) were studied 
using fi rst early log phase spirochetes and direct counting 
of the live/motile cells with dark fi eld microscope. Wild-
type and mutant spirochetes were treated with various 
concentrations of doxycycline (ranging from published 
MIC and MBC concentrations) for 48 h, and the number 
of motile spirochetes in each treatment was counted. Spi-
rochete numbers were normalized to their no antibiotic 
control of the same strains (0 μg/ml doxycycline) as de-
picted in Fig. 8. For all B. burgdorferi strains, doxycycline 
treatments that signifi cantly reduced the live spirochete 
Fig. 6. Aggregates of 297 (A), RpoN (B), RpoS (C), and LuxS (D) strains of B. burgdorferi stained with calcium specific stain, 
Alizarine, as described in Materials and methods. Red color indicates calcium analyzed by dark field microscopy. Black arrow-
heads indicate spirochetes not stained with Alizarine. 400× magnification, bar: 200 μm
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counts in every concentration were studied. More specifi -
cally, as doxycycline concentration increased from zero to 
1 μg/ml, spirochetes decreased in number from 100% to 
15–20% in every strain. Signifi cant differences between 
the wild-type 297 and all mutant strains (RpoN∆, RpoS∆, 
and Lux∆) were found (marked with #) when 0.1 μg/ml of 
concentration was used for treatment, while 1 μg/ml doxy-
cyline concentration showed more signifi cant results only 
in RpoN∆ and RpoS∆ strains but not in the LuxS∆ strain. 
Interestingly, however, 10 μg/ml doxycyline treatment did 
not produce signifi cantly different results in any of the mu-
tant strains compared to wild-type Borrelia strain.
In the next step of experiments of the crystal violet, 
total carbohydrate assay and Baclight Live/Dead stain-
ing methods were used to study the effect of doxycycline 
on the viability of the stationary phase aggregates formed 
by the wild-type and mutant B. burgdorferi strains. Crys-
tal violet measured the changes in total mass while total 
Fig. 7. Aggregates of the wild-type 297, RpoN, RpoS, and LuxS strains of B. burgdorferi stained eDNA with DDAO fluorescent dye 
specific for extracellular DNA as described in Materials and methods (panels B, D, F, and H). DAPI nuclear counterstain was used 
to demonstrate the structure of the different aggregates (panels A, C, E, and G). Red fluorescent color indicates eDNA as depicted 
by fluorescent microscopy. Yellow arrowheads indicate spirochetes not stained with DDAO. 400× magnification, bar: 200 μm
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carbohydrate assay was used to detect changes in the ex-
tracellular polysaccharide layer of the aggregates before 
and after antibiotic treatment. Baclight Live/Dead staining 
method directly visualized the effect of the doxycycline by 
depicting the live (green) and dead (red) population in the 
aggregates of the different Borrelia strains. Seven-day-old 
aggregate rich cultures (starting culture of 5 × 106 spiro-
chetal cells) in 1 mL suspension were treated with different 
concentration of doxycycline (ranging from 0 to 10 μg/ ml 
concentration) for 48 h. Data from all antibiotic-treated 
samples were normalized to their no antibiotic control of 
the same strains (0 μg/ml doxycycline). When crystal vio-
let method was used to evaluate doxycyline sensitivity of 
the wild-type and all three mutant strains, there were no 
signifi cant differences found for any of the experimental 
condition for any strains studied (data not shown). How-
ever, when the total carbohydrate assay was used to assess 
doxycyline sensitivity, there were signifi cant differences 
found in all three mutant strains compared to the wild-type 
control as depicted in Fig. 9. While doxycyline treatment 
of 297 wild-type strain did not reduce the extracellular 
polysaccharide layer signifi cantly at any of the antibiotic 
concentrations, all there mutant strains (RpoN∆, RpoS∆, 
and Lux∆) showed reduction of their extracellular poly-
saccharide layer at 10 μg/ml (20–60%). The most dramatic 
effect, however, was found in the doxycyline sensitivity of 
the LuxS∆ strain, indicating that all three concentrations of 
doxycyline (0.1, 1, and 10 μg/ml) signifi cantly reduced the 
extracellular polysaccharide layer (Fig. 9). The reduction 
was signifi cant when it was compared to both the LuxS∆ 
Fig. 8. Effect of different concentrations of doxycycline on the spirochetal form of wild-type 297 and RpoN∆, RpoS∆, and LuxS∆ 
strains of B. burgdorferi. The data analyzed by direct counting of the motile spirochetes using dark field microscopy. Each assay 
was carried out in three independent experiments with six sample replicates/condition, and the data were normalized to the no anti-
biotic treatment control for each strain. * indicates statistical significance as related to the corresponding no antibiotic control, and 
# indicates statistical significance as related to the 297-WT corresponding control sample
Fig. 9. Effect of different concentrations of doxycycline 48 h treatment on the biofilm form of wild-type 297 and RpoN∆, RpoS∆, 
and LuxS∆ mutant strains of B. burgdorferi after 48 h treatment analyzed by total carbohydrate methods as described in Materials 
and methods. Each assay was carried out in three independent experiments with six sample replicates/condition, and the data were 
normalized to the no antibiotic treatment control for each strain. * indicates statistical significance as related to the corresponding 
no antibiotic control, and # indicates statistical significance as related to the 297-WT corresponding control sample
Effect of different pathways on Borrelia biofilm
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control and 297 wild-type control (p value < 0.01). Fur-
thermore, while the effect of 10 μg/ml of doxycyline was 
signifi cant for the extracellular polysaccharide layer of the 
RpoN∆ and RpoS∆ strains when it compared to their no 
treatment controls (p value < 0.05), it was not signifi cantly 
different than the wild-type control data with the same 
doxycyline treatment.
To further confi rm the quantitative data of the doxy-
cyline effect on the different strains, Baclight Live/Dead 
analyses were performed on the 10 μg/ml doxycyline-
treated cultures after 48 h. Figure 10 shows representa-
tive microscopic images obtained from the untreated and 
doxycycline-treated wild-type 297 and mutant B. burg-
dorferi strains (RpoN∆, RpoS∆, and Lux∆) strains depict-
ing membrane-intact (live) cells in green and membrane-
permeable (dead) cells in red. In all of the no treatment 
controls (Fig. 10, panels A, C, E, and G), majority of the 
cells show green staining indicating live cells with a small 
portion of the cells stained red indicating dead cells. In 
the doxycyline-treated cultures, the majority of the cells 
stained green for the wild-type 297 and the RpoN∆ mutant 
cells show no signifi cant difference from their no treat-
ment control cultures. For RpoS∆ strain, there were a por-
tion of the aggregates (<10%) which showed higher num-
bers of dead cells, but overall, the difference from the no 
treatment control was not signifi cant. On the other hand, 
Fig. 10. Representative Baclight Live/Dead images of the effect of doxycycline on the aggregate forms of wild-type 297 (panels A 
and B) and RpoN∆ (panels C and D), RpoS∆ (panels E and F), and LuxS∆ (panels G and H) strains of Borrelia burgdorferi after 
48 h treatment with 0 (panels A, C, E, and G) or 10 μg/ml (panels B, D, F, and H) of doxycyline as analyzed using fluorescent mi-
croscopy. Green color = live cells, red color = dead cells, 400× magnification, bar: 200 μm
E. Sapi et al.
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majority (>95%) of the aggregates of the LuxS strains 
showed mainly red/dead cells after 48 h of antibiotic treat-
ment, suggesting a greater sensitivity to doxycyline than 
the wild-type 297 or the Rpo gene mutant strains.
Discussion
In this study, the possible biofi lm formation of several 
mutant strains of B. burgdorferi was investigated to better 
understand the roles of different genes–intracellular path-
ways in the development and characteristic of Borrelia 
biofi lm.
Building a biofi lm community requires intra- and ex-
tracellular communication processes and is considered a 
survival response in bacteria [36–38]. Rpo transcriptional 
factor genes are known to control bacterial changes in re-
sponse to environment stimuli [40]; LuxS quorum-sensing 
roles in biofi lm formation and antibiotic response have 
been established in some research with other organisms 
[47–50]. This study attempted to explore the possible roles 
of Rpo genetic regulation and LuxS quorum communica-
tion pathways in Borrelia biofi lm formation and its anti-
biotic sensitivity.
Growth patterns of planktonic spirochetes were com-
pared between the wild-type and the different mutant 
strains. The results showed that RpoN, RpoS, and LuxS 
mutant strains had some deviations from wild-type strains, 
including that mutants lacking Rpo genes had longer time 
to response to the inadequate nutrient environment, result-
ing in a longer exponential growth period and, ultimately, 
the higher maximum spirochete density. LuxS mutant 
reached the stationary phase later, suggesting that LuxS 
could also have a potential role in the growth of B. burg-
dorferi.
Furthermore, in spite of lacking important genes re-
sponsible for regulating bacterial environmental responses 
and quorum-sensing communication, all three mutants 
readily formed biofi lm-like aggregates in the station-
ary phase of growth. Morphologically, all mutants but 
especially the LuxS mutant seemed to exhibit a higher 
tendency to form smaller and looser aggregates than the 
wild-type strain. This result is in good agreement with a 
previous study in which mutation in rpoS did not eliminate 
the biofi lm formation in Escherichia coli during exponen-
tial phase of growth [54, 55].
The size of the aggregates was also quantifi ed in this 
study using crystal violet staining as well as total carbo-
hydrate quantitation methods. The obtained data indicated 
that mutant aggregates were signifi cantly smaller than the 
wild-type ones; however, those smaller aggregates had 
similar amounts of total carbohydrate, suggesting that the 
mutants might produce higher amounts of protective mu-
copolysaccharide layers. This fi nding is in good agreement 
with a study, in which Pseudomonas aeruginosa mutant 
had increased matrix production [56].
Further investigation of specifi c biofi lm markers in the 
mutant strains showed that all three mutant strains produce 
signifi cant amounts of biofi lm specifi c markers such as 
sulfated/non-sulfated polysaccharides, alginate, calcium, 
and eDNA, similar to what was found and reported pre-
viously to the wild-type B. burgdorferi strains [52, 53]. 
These results strongly suggest that the aggregates formed 
by the mutant strains studied are indeed biofi lms.
It might be surprising at fi rst that Borrelia strains lack-
ing RpoN, RpoS, and LuxS genes still can form bio-
fi lms which could have most of the main phenotypes of 
the wild-type biofi lm. However, in earlier studies, it was 
reported that mutant strains of RpoN in E. coli K12 and 
Entero coccus faecalis also formed biofi lms [57, 58]. RpoS 
mutant strain was also observed to form biofi lm in E. coli 
ZK126 stains as well as in P. aeroginosa [59, 60]. For LuxS 
mutant strain in Streptococccus sp., a report suggested that 
the mutant LuxS mutant could form biofi lm; however, it 
depends on the in vitro culture condition [61, 62].
One of main differences found for the Borrelia mutant 
biofi lms was the reduced size compared to wild-type 297. 
The RpoN mutant strain of B. burgdorferi formed a bio-
fi lm which was 22% less in size than the wild-type 297. 
Previously, it was reported that the deletion of RpoN gene 
in E. coli K12 strains increased the biofi lm formation by 
40–60%, and also in E. faecalis, the RpoN mutant strain 
was observed to form robust biofi lms [57, 58]. In this study, 
we showed that RpoS mutant strain of B. burgdorferi had 
16% reduction in the biofi lm formation compared to wild-
type similar to the deletion of RpoS gene in E. coli ZK126 
which reduced the biofi lm size by 50% [59]. LuxS mu-
tant strain of B. burgdorferi formed biofi lm which showed 
39% signifi cant reduction in size which agrees with the 
report on Streptococccus sp. LuxS mutants [61].
Also, there were slight morphological differences ob-
served in the biofi lms formed by the RpoN, RpoS, and 
LuxS Borrelia mutant strains compared to wild-type 
strain. The biofi lm formed by the wild-type 297 strain 
shows a compact biofi lm mass which resembles the bio-
fi lm of B31 strain of B. burgdorferi as described in our 
recently published paper [32, 33]. The biofi lm formed by 
RpoN mutant was relatively less compact compared to 
wild-type biofi lms while RpoS mutant strain formed many 
loose and dispersed small aggregates unlike the wild-type 
297. Interestingly, the biofi lm formed by RpoS mutant of 
P. aeroginosa was denser and thicker than the wild type 
[60]. The biofi lm formed by LuxS mutant strain of Bor-
relia represents a very loose reticular mesh. Undifferen-
tiated and loosely-connected biofi lms were also found 
to form in LuxS mutant strain of Shewanella oneidensis 
covering the entire glass surface uniformly unlike the 
wild type which forms compact biofi lms with signifi cant 
amounts of spaces in between [63].
Biofi lms were demonstrated to be responsible for the 
antibiotic resistance in many species [36–39]. Therefore, 
besides examining the growth dynamics and biofi lm de-
velopment of the different mutant strains of B. burgdor-
feri, this research attempted to compare the responses of 
wild-type and mutant strains to antibiotic stress. Early 
log phase spirochetes and stationary phase aggregate 
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rich cultures were exposed to varying concentrations of 
doxycycline and compared among all strains studies. In 
a good agreement with several recent studies using wild-
type B. burgdorferi 31 strain, only the early log phase 
spirochetes of the wild-type 297 strains were sensitive to 
doxycyline treatment but not the aggregate rich stationary 
phase cells [3–6]. When the doxycyline sensitivity of the 
early log phase spirochetes of the wild-type strain and all 
of the three mutant strains was compared, the obtained re-
sults indicated signifi cantly higher sensitivity of all three 
mutant strains to low MIC dose of doxycyline (0.1 μg/ml) 
than the wild-type strain. Interestingly, however, there was 
no difference in the doxycyline sensitivity of the early log 
phase spirochetes among the strains at higher MBC level 
concentration.
Similarly, doxycyline sensitivity of the stationary ag-
gregate rich cultures of wild-type and Rpo mutants was not 
signifi cantly different at lower doses. In contrary, however, 
antibiotic sensitivity of the LuxS Borrelia mutant dramati-
cally greater than the wild-type mutant at all concentra-
tions was studied. These later results were also confi rmed 
by microscopical analyses of the live and dead cells of the 
mutant strains as demonstrated by Baclight Live/Dead 
staining. In summary, the antibiotic sensitivity studies of 
the mutant strains confi rmed that all three genes have some 
effect on antibiotic sensitivity in some extent but LuxS 
mutant has the most signifi cant effect.
Involvement of LuxS signaling pathway in antibiotic 
sensitivity was proven for S. anginosus species, in which 
the mutant demonstrated increased susceptibility to eryth-
romycin and ampicillin [64]. Furthermore, P. aeruginosa 
mutants defective in interspecies quorum sensing pro-
duced weaker biofi lms that were more sensitive to deter-
gents, while Streptococcus mutans mutants defective in 
interspecies cell signaling generated stronger biofi lms that 
were more resistant to detergents [61, 65].
In our recent studies, we also investigate the potential 
biofi lm formation of several other B. burgdorferi mutants 
such as the Hk1/Rrp1 and recA mutants that regulate the 
cyclic di-GMP and the recombination events, respectively 
[38, 66, 67]. Those two molecular pathways were already 
implicated to be important in biofi lm formation for other 
bacterial species [38]; however, our preliminary fi ndings 
show no differences from the wild-type strains in regards 
of different aspects of biofi lm development and character-
istic (data not shown).
In summary, our fi ndings strongly suggest that several 
alternative pathways could regulate B. burgdorferi biofi lm 
formation, a result that indicates that it is a very important 
survival mechanism for this bacterium. Findings for the 
potential importance of the LuxS quorum-sensing path-
ways for Borrelia biofi lm development and antibiotic sen-
sitivity merit further investigation of this pathway.
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